Mouse Anti-DLGAP1 Recombinant Antibody (2A6) (CBMAB-A2253-LY)

Takahashi, Y., Yamazaki, K., Kamatani, Y., Kubo, M., Matsuda, K., & Asai, S. (2021). A genome-wide association study identifies a novel candidate locus at the DLGAP1 gene with susceptibility to resistant hypertension in the Japanese population. Scientific reports, 11(1), 1-11.

Lu, J., Xu, Y., Xie, W., Tang, Y., Zhang, H., Wang, B., ... & Zhang, W. (2021). Long noncoding RNA DLGAP1-AS2 facilitates Wnt1 transcription through physically interacting with Six3 and drives the malignancy of gastric cancer. Cell death discovery, 7(1), 1-12.

Zhang, J., Yang, J., Yang, N., Ma, J., Lu, D., Dong, Y., ... & Cang, M. (2020). Dlgap1 negatively regulates browning of white fat cells through effects on cell proliferation and apoptosis. Lipids in health and disease, 19(1), 1-10.

Fan, Z., Qian, Y., Lu, Q., Wang, Y., Chang, S., & Yang, L. (2018). DLGAP 1 and NMDA receptor‐associated postsynaptic density protein genes influence executive function in attention deficit hyperactivity disorder. Brain and behavior, 8(2), e00914.

Coba, M. P., Ramaker, M. J., Ho, E. V., Thompson, S. L., Komiyama, N. H., Grant, S. G. N., ... & Dulawa, S. C. (2018). Dlgap1 knockout mice exhibit alterations of the postsynaptic density and selective reductions in sociability. Scientific reports, 8(1), 1-12.

Please try the standard protocols which include: protocols, troubleshooting and guide.

Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme-Linked Immunospot (ELISpot)
Proteogenomics
Other Protocols